Quick Answer
BIOVIE INC. reported Net Income of -$17.54 million for fiscal year 2025.
BIOVIE INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net Income | -$17.54M +45.4% |
-$32.12M +36.1% |
-$50.26M -92.7% |
-$26.08M +80.0% |
-$130.25M -681.0% |
-$16.68M |
| Diluted EPS | -$12.12 +83.4% |
-$73.05 -372.2% |
-$15.47 -1359.4% |
-$1.06 +92.8% |
-$14.82 -116.4% |
-$6.85 -599.0% |
| Total Assets | $21.56M -14.5% |
$25.21M -28.2% |
$35.10M +74.5% |
$20.11M +232.7% |
$6.05M +190.2% |
$2.08M -19.1% |
| Cash and Equivalents | $17.54M -26.4% |
$23.84M +22.5% |
$19.46M +4.4% |
$18.64M | — | — |
| Long-Term Debt | — | — | — | — | — | $62.5K |
| Stockholders Equity | $19.01M +22.6% |
$15.51M +1.1% |
$15.34M +317.9% |
$3.67M -27.3% |
$5.05M +123.5% |
-$21.50M -1108.9% |
| R&D Expense | $9.27M -59.9% |
$23.10M -30.6% |
$33.30M +92.9% |
$17.26M +578.2% |
$2.54M +121.2% |
$1.15M +14.1% |
| Operating Income | -$18.07M +43.9% |
-$32.18M +28.6% |
-$45.08M -65.4% |
-$27.25M +80.3% |
-$138.05M -5026.6% |
-$2.69M -7.9% |
| Shares Outstanding | 1.91M +209.2% |
619,008 -83.0% |
3.64M -85.4% |
24.98M +11.9% |
22.33M +329.1% |
5.20M +28.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2016 | $0.00 | — | — |
| Net Income | December 31, 2025 | -$6.07M | +14.7% | -19.3% |
| Diluted EPS | December 31, 2025 | -$0.77 | +83.1% | +21.4% |
| Total Assets | December 31, 2025 | $22.50M | -12.4% | -16.1% |
| Cash and Equivalents | December 31, 2025 | $20.54M | -15.8% | -17.8% |
| Long-Term Debt | March 31, 2021 | $62.5K | — | +0.0% |
| Stockholders Equity | December 31, 2025 | $19.27M | -19.5% | -22.7% |
| R&D Expense | December 31, 2025 | $4.27M | -9.3% | +45.4% |
| Operating Income | December 31, 2025 | -$6.26M | +14.1% | -18.5% |
| Shares Outstanding | December 31, 2025 | 7.54M | -59.1% | +0.0% |
- BIOVIE INC. reported Net Income of -$17.54 million for fiscal year 2025.
- BIOVIE INC. showed an increase of +45.4% in Net Income compared to the prior fiscal year.
- BIOVIE INC. reported Diluted EPS of $12.12 per share (loss) for fiscal year 2025.
- BIOVIE INC. showed an increase of +83.4% in Diluted EPS compared to the prior fiscal year.
- BIOVIE INC. reported Total Assets of $21.56 million for fiscal year 2025.
- BIOVIE INC. showed a decrease of -14.5% in Total Assets compared to the prior fiscal year.
- BIOVIE INC. reported Cash and Equivalents of $17.54 million for fiscal year 2025.
- BIOVIE INC. showed a decrease of -26.4% in Cash and Equivalents compared to the prior fiscal year.
- BIOVIE INC. reported Long-Term Debt of $62.5 thousand for fiscal year 2020.
- BIOVIE INC. reported Stockholders Equity of $19.01 million for fiscal year 2025.
- BIOVIE INC. showed an increase of +22.6% in Stockholders Equity compared to the prior fiscal year.
- BIOVIE INC. reported R&D Expense of $9.27 million for fiscal year 2025.
- BIOVIE INC. showed a decrease of -59.9% in R&D Expense compared to the prior fiscal year.
- BIOVIE INC. reported Operating Income of -$18.07 million for fiscal year 2025.
- BIOVIE INC. showed an increase of +43.9% in Operating Income compared to the prior fiscal year.
- BIOVIE INC. reported Shares Outstanding of 1.91 million shares for fiscal year 2025.
- BIOVIE INC. showed an increase of +209.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: